Palla Pharma (ASX:PAL) Short-Term Capital Lease Obligation : A$0.00 Mil (As of Jun. 2021)

View and export this data going back to 2015. Start your Free Trial

What is Palla Pharma Short-Term Capital Lease Obligation?

Palla Pharma's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2021 was A$0.00 Mil.

Palla Pharma's quarterly Short-Term Capital Lease Obligation increased from Jun. 2020 (A$0.00 Mil) to Dec. 2020 (A$0.04 Mil) but then declined from Dec. 2020 (A$0.04 Mil) to Jun. 2021 (A$0.00 Mil).

Palla Pharma's annual Short-Term Capital Lease Obligation stayed the same from Dec. 2018 (A$0.00 Mil) to Dec. 2019 (A$0.00 Mil) but then increased from Dec. 2019 (A$0.00 Mil) to Dec. 2020 (A$0.04 Mil).

Palla Pharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for Palla Pharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palla Pharma Short-Term Capital Lease Obligation Chart

Palla Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.60

8.15

0.04

Palla Pharma Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial							-	-	-	0.04	-

Palla Pharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Palla Pharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Palla Pharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Palla Pharma (ASX:PAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Palla Pharma Ltd (ASX:PAL) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Mertons Corporate Services, 330 Collins Street, Level 7, Melbourne, VIC, AUS, 3000

Website

http://www.tpienterprises.com

Palla Pharma Ltd is a licensed poppy processor in Australia. It is engaged in producing narcotic raw material for the international pharmaceutical industry. It also supplies narcotic raw material and culinary poppy seed.

Palla Pharma (ASX:PAL) Headlines

From GuruFocus

Proficient Auto Logistics Announces Pricing of Initial Public Offering

By Business Wire • 05-09-2024